Use access key #2 to skip to page content.
$71.74 -0.95 (-1.31%)
10/7/2008 3:45 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

1

Avatar cerebos (< 20) Submitted: 7/06/07 4:35 PM : Underperform Start Price: $61.20 GENZ Score: -51.91

Great company but will be punished in the short term for having had unsuccessful outcomes of two clinical trials.

Report this Post Replies: 0 | Reply

Featured Broker Partners